Overview
- Iluvatar CoreX is preparing a Hong Kong secondary offering that reports say could raise at least $800 million and possibly as much as $850 million after its post‑IPO lock‑up expired on July 7.
- The deal would nearly double the company’s public fundraising to roughly $1.3 billion since its January IPO, increasing share supply and creating dilution pressure for existing holders.
- Practical terms reported by the South China Morning Post show an accelerated placement of about 14.9 million shares priced at HK$476 each, representing a roughly 15% discount to the prior close.
- The company says it makes general‑purpose GPUs for AI training and inference; proceeds are expected to pay for costly chip manufacturing capacity and R&D to compete with firms such as Huawei and Cambricon and to narrow the gap with Nvidia.
- Iluvatar is in advanced talks to sell at least 50,000 inference chips to ByteDance, a move that could validate demand but would concentrate revenue risk if a single customer takes a large share of sales.